Rheumnow Podcast

ACR 2025 Daily Podcasts Day2c

·39 min·3 clips
Richard Conway reports that NSAIDs reduced new spinal bone growth by 22% in a study of 262 ankylosing spondylitis patients.
The podcast opens in Chicago at ACR 2025. Richard Conway reports for Room Now and focuses on abstract 2359, a poster presentation by Consta et al. The study looks at radiographic axial spondyloarthritis, also called ankylosing spondylitis, and asks whether NSAIDs add anything to TNF inhibitors in limiting radiographic progression. It includes 262 patients, with 100 on NSAIDs plus TNF inhibitors and 162 on TNF inhibitors alone. New syndesmophytes appear in 36 percent of the NSAID group and 58 percent of the group without NSAIDs. The change in modified Stoke Ankylosing Spondylitis Spinal Score is 0.1 in the NSAID group and 0.7 in the comparison group. Hip changes do not differ between the two groups. Conway suggests this may indicate a specific effect on spinal radiographic change, probably because those spine findings are more osteoproliferative. A later segment turns to handedness and erosion scores. The speaker says left-handed people had worse erosion scores on both hands, with the left hand showing the stronger association. Mechanical stress from tools and other things made for right-handed people is raised as one possible explanation. The speaker also allows for confounding that was missed. Another possibility is that the score used did not capture all of the damage. The speaker adds that the finding has not been reproduced in another cohort. Brian Jaros then speaks with Dr. Brendan Denver, a third-year rheumatology fellow at Johns Hopkins. Denver is looking at airway disease in GPA, which he describes as a nagging manifestation that can stay refractory even when GPA medications perform well in clinical trials. The show closes with Dr. Plantinga, who frames the next step as following people with impairments or restrictions over several years and then pulling more cohorts together. He points to activities of daily living, physical function, and polypharmacy as the issues that matter on the ground.

As heard by us

A Chicago ACR dispatch that keeps the data front and center while staying careful about what the findings can support.

Richard Conway opens this ACR 2025 dispatch with abstract 2359 from Consta et al, a poster on NSAIDs in radiographic axial spondyloarthritis, then moves briskly through a handedness-and-erosion discussion before landing on airway disease in GPA.

Read the full review in PlayNext →

Why you'd press play

When you want ACR 2025 numbers before the coffee goes cold.

Read the full recommendation in PlayNext →
Listen to the show on